In patients, CSP1 is highest in tumors with LKB1 loss and is correlated with poorer patient prognosis in stage I/II LUAD but not in later stages, suggesting a role for CSP1 in tumor initiation and/or progression. The gene discussed is CSP1; the disease is neoplasm.